These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3711799)

  • 1. Eumelanin-related indolic compounds in the urine of treated melanoma patients.
    Pavel S; Elzinga H; Muskiet FA; Smit JM; Mulder NH; Koops HS
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):167-73. PubMed ID: 3711799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
    Pavel S; Muskiet FA
    Cancer Detect Prev; 1983; 6(1-2):311-6. PubMed ID: 6883388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.
    Pavel S; Muskiet FA; Budesínská A; Duchon J
    Tumori; 1981 Aug; 67(4):325-32. PubMed ID: 6797117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Thormählen-positive compound "B" in urine of patients with malignant melanoma.
    Pavel S; Boverhof R; van der Slik W
    Arch Dermatol Res; 1984; 276(3):156-9. PubMed ID: 6548107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ester glucuronide and sulfate conjugates of 5-hydroxy-6-methoxyindole-2-carboxylic acid and 6-hydroxy-5-methoxyindole-2-carboxylic acid in melanoma urine.
    Wakamatsu K; Ito S
    J Dermatol Sci; 1990 Jul; 1(4):253-9. PubMed ID: 2095194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolic urinary melanogens: separation and identification by gas chromatography with selected-ion monitoring mass spectrometry of 5-hydroxy-6-methoxyindole-2-carboxylic and 5-methoxy-6-hydroxyindole-2- carboxylic acids.
    Duthel JM; Vallon JJ
    J Chromatogr; 1991 Sep; 570(1):166-72. PubMed ID: 1797822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of eumelanin in human urine.
    Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
    Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
    Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
    Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry.
    Pavel S; Muskiet FA; de Ley L; The TH; van der Slik W
    J Cancer Res Clin Oncol; 1983; 105(3):275-9. PubMed ID: 6853590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of eumelanin-related metabolites 5,6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, and their O-methyl derivatives.
    Wakamatsu K; Ito S
    Anal Biochem; 1988 May; 170(2):335-40. PubMed ID: 3394933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some indolic compounds as markers of the melanocyte activity.
    Hansson C
    Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased excretion of indolemelanogens in malignant melanoma without liver metastasis].
    Schwartze G; Haneke E
    Dermatol Monatsschr; 1969; 155(2):99-102. PubMed ID: 5386292
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of 5-hydroxy-6-indolyl-O-sulfate in urine of patients with malignant melanoma.
    Pavel S; Boverhof R; Wolthers BG
    J Invest Dermatol; 1984 Jun; 82(6):577-9. PubMed ID: 6547157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple screening test for estimation of some phenolic and indolic compounds in urine application to melanoma.
    Pavel S; Matous B; Duchon J
    J Invest Dermatol; 1978 Apr; 70(4):197-9. PubMed ID: 641370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 5,6-dimethoxyindolyl-2-carboxylic acid in melanotic urine.
    Pavel S; Elzinga H; Muskiet FA; Wolthers BG
    Acta Derm Venereol; 1983; 63(4):340-3. PubMed ID: 6195867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two Thormählen-positive compounds from melanotic urine by gas chromatography-mass spectrometry.
    Pavel S; Muskiet FA; Nagel GT; Schwippelová Z; Duchon J
    J Chromatogr; 1981 Mar; 222(3):329-36. PubMed ID: 7228942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of cysteinyldopa in the follow-up of disseminated malignant melanoma.
    Kärnell R; Kågedal B; Lindholm C; Nilsson B; Arstrand K; Ringborg U
    Melanoma Res; 2000 Aug; 10(4):363-9. PubMed ID: 10985671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.